Ocular Adverse Events after Inactivated COVID-19 Vaccination in Xiamen

Ocular Adverse Events after Inactivated COVID-19 Vaccination in Xiamen

<b>Aims:</b> To report potential vaccine-induced ocular adverse events following inactivated COVID-19 vaccination (Sinopharm and Sinovac). <b>Methods:</b> This case series took place at a tertiary referral center in the southeast of China (Xiamen Eye Center in Fujian Province...

Full description

Bibliographic Details
Main Authors:	Xiuju Chen, Xiaoxin Li, Haibo Li, Minghan Li, Songjian Gong
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Vaccines
Subjects:	COVID-19 inactivated vaccine ocular adverse events vaccine-induced uveitis
Online Access:	https://www.mdpi.com/2076-393X/10/3/482

Similar Items

Inflammatory ocular events after inactivated COVID-19 vaccination
by: Ping Fei, et al.
Published: (2022-11-01)

Ocular Adverse Events after Inactivated COVID-19 Vaccination
by: Zhihua Li, et al.
Published: (2022-06-01)

Case Report: Associated Ocular Adverse Reactions With Inactivated COVID-19 Vaccine in China
by: Kunpeng Pang, et al.
Published: (2022-01-01)

Acute-onset Vogt-Koyanagi-Harada like uveitis following Covid-19 inactivated virus vaccination
by: Xiuju Chen, et al.
Published: (2022-06-01)

Vaccine Adverse Events Following COVID-19 Vaccination with Inactivated Vaccines in Zimbabwe
by: Azure Tariro Makadzange, et al.
Published: (2022-10-01)

Vision-Threatening Ocular Adverse Events after Vaccination against Coronavirus Disease 2019
by: Mihyun Choi, et al.
Published: (2022-06-01)

Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine
by: Huakun Lv, et al.
Published: (2021-11-01)

Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System
by: Cyril N. A. Nyankerh, et al.
Published: (2022-06-01)

There Is No Evidence That Inactivated COVID-19 Vaccines Increase Risks of Uveitis Flare
by: Hang Song, et al.
Published: (2022-10-01)

Ocular Inflammation Post-Vaccination
by: Yaru Zou, et al.
Published: (2023-10-01)

Self-Reported adverse events among Chinese healthcare workers immunized with COVID-19 vaccines composed of inactivated SARS-CoV-2
by: Yandong Cheng, et al.
Published: (2022-11-01)

Surveillance of adverse events following the introduction of inactivated poliovirus vaccine made from Sabin strains (sIPV) to the Chinese EPI and a comparison with adverse events following inactivated poliovirus vaccine made from wild strains (wIPV) in Jiangsu, China
by: Guodong Kang, et al.
Published: (2021-08-01)

A review of ocular adverse events of biological anti-TNF drugs
by: Fernanda Nicolela Susanna, et al.
Published: (2020-04-01)

A Comparison with Adverse Events Following Immunization Associated with Sabin-Strains and Salk-Strains Inactivated Polio Vaccines in Zhejiang Province, China
by: Huakun Lv, et al.
Published: (2022-02-01)

Posner-Schlossman syndrome relapse following inactivated COVID-19 vaccination in China
by: Qilian Sheng, et al.
Published: (2023-01-01)

Some adverse events following immunization in veterinary medicine
by: Vesna Milićević, et al.
Published: (2018-09-01)

Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer
by: Lin Zhou, et al.
Published: (2021-08-01)

Analysis of participant-reported adverse events following the first dose of inactivated SARS-Cov-2 vaccine (TURKOVAC™) through telephone survey in Türkiye
by: Ateş Kara, et al.
Published: (2023-12-01)

Complications and adverse events of plaque brachytherapy for ocular melanoma
by: Krishi Peddada, et al.
Published: (2019-08-01)

Post-marketing surveillance study to assess the safety and tolerability of an Inactivated Poliomyelitis Vaccine in Indian children
by: Hitt Sharma, et al.
Published: (2017-11-01)

Safety monitoring in inactivated COVID-19 vaccines by clinical pharmacists from a single center in China
by: Min Hu, et al.
Published: (2022-09-01)

Self-Reported Allergic Adverse Events Following Inactivated SARS-CoV-2 Vaccine (TURKOVAC™) among General and High-Risk Population
by: Ateş Kara, et al.
Published: (2023-02-01)

Smallpox Vaccination and Adverse Cardiac Events
by: Lorna E. Thorpe, et al.
Published: (2004-05-01)

Ocular Vascular Events following COVID-19 Vaccines: A Systematic Review
by: Hashem Abu Serhan, et al.
Published: (2022-12-01)

The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose
by: Liling Chen, et al.
Published: (2023-01-01)

COVID-19 Vaccine-Associated Ocular Adverse Effects: An Overview
by: Parul Ichhpujani, et al.
Published: (2022-11-01)

Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases
by: Hossein Azarpanah, et al.
Published: (2021-09-01)

Orbital Cellulitis following COVID-19 Vaccination
by: András Hári-Kovács, et al.
Published: (2022-03-01)

Adverse events following vaccination against coronavirus disease 2019
by: Minji Jeon, et al.
Published: (2022-03-01)

Adverse events following immunization of combined diphtheria, whole-cell pertussis, tetanus, and hepatitis B (DPwT/HB) vaccine
by: Diana Mettadewi Jong, et al.
Published: (2016-10-01)

OAE-based data mining and modeling analysis of adverse events associated with three licensed HPV vaccines
by: Wenrui Zi, et al.
Published: (2022-11-01)

Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination
by: Zhao WM, et al.
Published: (2022-06-01)

Adverse Events to Comirnaty Vaccine Are Linked to Sex, Age and BMI: Should We Consider Reducing the Dose for Females?
by: Elena Azzolini, et al.
Published: (2023-02-01)

Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
by: AbdulAzeez Adeyemi Anjorin, et al.
Published: (2022-04-01)

Adverse Events of Trivalent Influenza Vaccine among Health Care Workers in Iran
by: M Hajiabdolbaghi, et al.
Published: (2009-06-01)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
by: Juan Li, et al.
Published: (2021-10-01)

PRINCIPLES OF MONITORING OF ADVERSE EVENTS AFTER VACCINATION IN RUSSIAN FEDERATION AND THE WORLD
by: E. P. Nacharova, et al.
Published: (2017-02-01)

Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006–2015
by: Elaine R. Miller, et al.
Published: (2018-08-01)

Evaluatıon of adverse events following immunization reported during national immunization programs (Between 2017-2019 in Ankara Province)
by: A. Çigdem Simsek, et al.
Published: (2021-07-01)

Thoughts on fund compensation of adverse events following immunization in China
by: SU Ting, et al.
Published: (2022-04-01)